Glycobiology, Vol 9, 389-398, Copyright © 1999 by Oxford University Press
CJ Reid, MD Burdick, MA Hollingsworth and A Harris
The cause of the mucus clearance problems associated with cystic fibrosis
remains poorly understood though it has been suggested that mucin
hypersecretion, dehydration of mucins, and biochemical abnormalities in the
glycosylation of mucins may be responsible. Since the biochemical and
biophysical properties of a mucin are dependent on O-glycosylation, our aim
was to evaluate the O-glycosylation of a single mucin gene product in
matched pairs of cells that differed with respect to CFTR expression. An
epitope-tagged MUC1 mucin cDNA (MUC1F) was used to detect variation in
mucin glycosylation in stably transfected colon carcinoma cell lines HT29
and Caco2. The glycosylation of MUC1F mucin was evaluated in matched pairs
of Caco2 cell lines that either express wild-type CFTR or have
spontaneously lost CFTR expression. The general glycosylation pattern of
MUC1F was evaluated by determining its reactivity with a series of
monoclonal antibodies against known blood group and tumor-associated
carbohydrate antigens. Metabolic labeling experiments were used to estimate
the gross levels of glycosylation and sulfation of MUC1F mucin in these
matched pairs of cell lines. Expression of CFTR in this experimental system
did not affect the gross levels of glycosylation or sulfation of the MUC1F
mucin nor the types of carbohydrates structures attached to the MUC1F
protein.
ORIGINAL ARTICLES
CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines
Paediatric Molecular Genetics, Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Oxford OX3 9DS, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. L Schulz, A. J Sloane, L. J Robinson, S. S Prasad, R. A Lindner, M. Robinson, P. T Bye, D. W Nielson, J. L Harry, N. H Packer, et al. Glycosylation of sputum mucins is altered in cystic fibrosis patients Glycobiology, July 1, 2007; 17(7): 698 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Machen Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol, August 1, 2006; 291(2): C218 - C230. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parry, F. G. Hanisch, S.-H. Leir, M. Sutton-Smith, H. R. Morris, A. Dell, and A. Harris N-Glycosylation of the MUC1 mucin in epithelial cells and secretions Glycobiology, July 1, 2006; 16(7): 623 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Leir, S. Parry, T. Palmai-Pallag, J. Evans, H. R. Morris, A. Dell, and A. Harris Mucin Glycosylation and Sulphation in Airway Epithelial Cells Is Not Influenced by Cystic Fibrosis Transmembrane Conductance Regulator Expression Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 453 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Silverman, M. Sutton-Smith, K. McDermott, P. Heal, S.-H. Leir, H. R. Morris, M. A. Hollingsworth, A. Dell, and A. Harris The contribution of tandem repeat number to the O-glycosylation of mucins Glycobiology, April 1, 2003; 13(4): 265 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Silverman, S. Parry, M. Sutton-Smith, M. D. Burdick, K. McDermott, C. J. Reid, S. K. Batra, H. R. Morris, M. A. Hollingsworth, A. Dell, et al. In vivo glycosylation of mucin tandem repeats Glycobiology, June 1, 2001; 11(6): 459 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Gibson, W. G. Hill, and O. A. Weisz Evidence against the acidification hypothesis in cystic fibrosis Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1088 - C1099. [Abstract] [Full Text] [PDF] |
||||


